Home Suitability of Collection Tubes with Separator Gels for Collecting and Storing Blood Samples for Therapeutic Drug Monitoring (TDM)
Article
Licensed
Unlicensed Requires Authentication

Suitability of Collection Tubes with Separator Gels for Collecting and Storing Blood Samples for Therapeutic Drug Monitoring (TDM)

  • Jouni Karppi , Kari K. Åkerman and Markku Parviainen
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 38 Issue 4

Abstract

In this study, we present significant changes occurring in serum drug concentrations while using blood collection tubes that contain a barrier gel. This report also contains results with antidepressant drugs, which have not been studied before with human samples. The drug concentrations were measured either with high performance liquid chromatography (HPLC) or fluorescence polarization immunoassay (FPIA). The results show that gel tubes are suitable for blood collection for antiepileptic, antibiotic, asthma and cardioactive drug measurements, since only slight adsorption was seen (0–5%). However, the studied tubes are not suitable for blood collection of antidepressants nor benzodiazepines, because the adsorption can be 5–30%. The adsorption was even higher (up to 40%) when samples were stored for 24 h after centrifugation in gel tubes. When the centrifugation step was performed after storage the effect of the barrier gel was lower (only 0–13%). Antidepressant drug measurements performed from patient specimens collected in the studied gel tubes and stored for 3 h showed <10% adsorption of the studied drugs. After 24 h storage time, concentrations of all analysed drugs decreased even more: adsorbed amount of drugs were about 5–20%. The studied gel tubes are proposed to be satisfactory for blood collection for antidepressant drug measurements if separation step is performed within 3 h after blood clotting. With the spiked samples the adsorption to barrier gel was higher, so it seems that adsorption is faster when drugs are not highly bound to serum proteins.

:
Published Online: 2005-06-01
Published in Print: 2000-04-30

Copyright © 2000 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. The Clinical Usefulness of the Measurement of Cytokines
  2. Measurement of Cholesterol and other Lipoprotein Constituents in the Clinical Laboratory
  3. Serum ras (p21) as a Marker for Occupationally Derived Lung Cancer?
  4. Macro Lactate Dehydrogenase in a Patient with Myocarditis
  5. Elimination of Serum Complexed Prostate-Specific Antigen after Radical Retropubic Prostatectomy
  6. Suitability of Collection Tubes with Separator Gels for Collecting and Storing Blood Samples for Therapeutic Drug Monitoring (TDM)
  7. Influence of in vivo Hemoglobin Carbamylation on HbA1c Measurements by Various Methods
  8. Comparison of the Abbott IMx® and a High-Performance Liquid Chromatography Method for Measuring Total Plasma Homocysteine
  9. Evaluation of the ADVIA® Centaur™ TSH-3 Assay
  10. Biochemical Composition and Electrolyte Balance of "Unstimulated" Whole Human Saliva
  11. Evaluation of a New Simple and Rapid Enzyme-Linked Immunosorbent Assay Kit for Neopterin Determination
  12. Analytical and Clinical Evaluation of Troponin I Determination on Dimension RXL-HM
  13. Use of Ion-Selective Electrodes for Blood-Electrolyte Analysis. Recommendations for Nomenclature, Definitions and Conventions
  14. FESCC Survey on Accreditation and Post-Graduate Training in Clinical Chemistry in European Countries
  15. Clinical Use of Soluble Transferrin Receptor
  16. Macro Creatine Kinase Type 1: a Clinically Significant Marker?
  17. Vitamin B12 and B12-Proteins. By Bernhard Kräutler, Duilio Arigoni and Bernard T. Golding, editors
  18. The Bone and Mineral Manual – a Practical Guide. By Michael Kleerekoper, Ethel Sins, Michael McClung, editors
Downloaded on 11.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2000.045/html
Scroll to top button